UniProt ID | PPAC_HUMAN | |
---|---|---|
UniProt AC | P24666 | |
Protein Name | Low molecular weight phosphotyrosine protein phosphatase | |
Gene Name | ACP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 158 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Acts on tyrosine phosphorylated proteins, low-MW aryl phosphates and natural and synthetic acyl phosphates. Isoform 3 does not possess phosphatase activity.. | |
Protein Sequence | MAEQATKSVLFVCLGNICRSPIAEAVFRKLVTDQNISENWRVDSAATSGYEIGNPPDYRGQSCMKRHGIPMSHVARQITKEDFATFDYILCMDESNLRDLNRKSNQVKTCKAKIELLGSYDPQKQLIIEDPYYGNDSDFETVYQQCVRCCRAFLEKAH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEQATKSV ------CHHHHHHHH | 20.01 | 1587862 | |
7 | Ubiquitination | -MAEQATKSVLFVCL -CHHHHHHHHHHHHC | 41.40 | - | |
7 | Ubiquitination | -MAEQATKSVLFVCL -CHHHHHHHHHHHHC | 41.40 | - | |
8 | Phosphorylation | MAEQATKSVLFVCLG CHHHHHHHHHHHHCC | 21.50 | 63715447 | |
13 | S-palmitoylation | TKSVLFVCLGNICRS HHHHHHHHCCHHCCC | 2.93 | 29575903 | |
18 | S-palmitoylation | FVCLGNICRSPIAEA HHHCCHHCCCHHHHH | 4.01 | 29575903 | |
20 | Phosphorylation | CLGNICRSPIAEAVF HCCHHCCCHHHHHHH | 19.08 | 21815630 | |
29 | Ubiquitination | IAEAVFRKLVTDQNI HHHHHHHHHHCCCCC | 35.53 | - | |
29 | Ubiquitination | IAEAVFRKLVTDQNI HHHHHHHHHHCCCCC | 35.53 | - | |
32 | Phosphorylation | AVFRKLVTDQNISEN HHHHHHHCCCCCCCC | 42.16 | 20068231 | |
37 | Phosphorylation | LVTDQNISENWRVDS HHCCCCCCCCCCCCC | 32.21 | 20068231 | |
44 (in isoform 2) | Phosphorylation | - | 19.56 | 28348404 | |
44 | Phosphorylation | SENWRVDSAATSGYE CCCCCCCCCCCCCCC | 19.56 | 28796482 | |
47 | Phosphorylation | WRVDSAATSGYEIGN CCCCCCCCCCCCCCC | 23.54 | 28796482 | |
48 | Phosphorylation | RVDSAATSGYEIGNP CCCCCCCCCCCCCCC | 34.35 | 28796482 | |
48 (in isoform 2) | Phosphorylation | - | 34.35 | 28348404 | |
50 | Phosphorylation | DSAATSGYEIGNPPD CCCCCCCCCCCCCCC | 12.25 | 28796482 | |
55 (in isoform 2) | Phosphorylation | - | 20.23 | 28348404 | |
58 | Phosphorylation | EIGNPPDYRGQSCMK CCCCCCCCCCCHHHH | 23.55 | 28796482 | |
62 | Phosphorylation | PPDYRGQSCMKRHGI CCCCCCCHHHHHHCC | 21.00 | 21652233 | |
62 (in isoform 2) | Phosphorylation | - | 21.00 | 24719451 | |
66 | Methylation | RGQSCMKRHGIPMSH CCCHHHHHHCCCHHH | 13.33 | - | |
79 (in isoform 3) | Ubiquitination | - | 21.75 | 21890473 | |
79 | Phosphorylation | SHVARQITKEDFATF HHHHHHCCHHHHCCC | 21.75 | 116521 | |
80 | Ubiquitination | HVARQITKEDFATFD HHHHHCCHHHHCCCC | 57.84 | - | |
85 | Phosphorylation | ITKEDFATFDYILCM CCHHHHCCCCEEEEE | 19.62 | 46157949 | |
88 | Nitration | EDFATFDYILCMDES HHHCCCCEEEEECHH | 7.50 | - | |
88 | Phosphorylation | EDFATFDYILCMDES HHHCCCCEEEEECHH | 7.50 | 28796482 | |
92 | Sulfoxidation | TFDYILCMDESNLRD CCCEEEEECHHHHHH | 6.01 | 30846556 | |
109 | Phosphorylation | RKSNQVKTCKAKIEL HHCHHHHHHHHHHHH | 22.00 | 30576142 | |
113 | Sumoylation | QVKTCKAKIELLGSY HHHHHHHHHHHHCCC | 23.39 | - | |
113 (in isoform 2) | Ubiquitination | - | 23.39 | 21890473 | |
113 (in isoform 1) | Ubiquitination | - | 23.39 | 21890473 | |
113 | Acetylation | QVKTCKAKIELLGSY HHHHHHHHHHHHCCC | 23.39 | 26051181 | |
113 | 2-Hydroxyisobutyrylation | QVKTCKAKIELLGSY HHHHHHHHHHHHCCC | 23.39 | - | |
113 | Ubiquitination | QVKTCKAKIELLGSY HHHHHHHHHHHHCCC | 23.39 | 21890473 | |
113 | Sumoylation | QVKTCKAKIELLGSY HHHHHHHHHHHHCCC | 23.39 | - | |
119 | Phosphorylation | AKIELLGSYDPQKQL HHHHHHCCCCCCCCE | 26.74 | 30576142 | |
120 | Phosphorylation | KIELLGSYDPQKQLI HHHHHCCCCCCCCEE | 29.82 | 30460777 | |
124 | Ubiquitination | LGSYDPQKQLIIEDP HCCCCCCCCEEEECC | 53.08 | - | |
132 | Phosphorylation | QLIIEDPYYGNDSDF CEEEECCCCCCCCCH | 36.01 | 19605366 | |
133 | Phosphorylation | LIIEDPYYGNDSDFE EEEECCCCCCCCCHH | 18.16 | 19605366 | |
137 | Phosphorylation | DPYYGNDSDFETVYQ CCCCCCCCCHHHHHH | 48.47 | 28464451 | |
141 | Phosphorylation | GNDSDFETVYQQCVR CCCCCHHHHHHHHHH | 25.22 | 28796482 | |
143 | Phosphorylation | DSDFETVYQQCVRCC CCCHHHHHHHHHHHH | 10.57 | 54129 | |
156 | Ubiquitination | CCRAFLEKAH----- HHHHHHHHHC----- | 54.64 | 19608861 | |
156 | Acetylation | CCRAFLEKAH----- HHHHHHHHHC----- | 54.64 | 19608861 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PPAC_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PPAC_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SMBT1_HUMAN | SFMBT1 | physical | 16189514 | |
RM20_HUMAN | MRPL20 | physical | 16169070 | |
FBP1L_HUMAN | FNBP1L | physical | 16169070 | |
EPHA2_HUMAN | EPHA2 | physical | 12167657 | |
RL12_HUMAN | RPL12 | physical | 22939629 | |
ABRAL_HUMAN | ABRACL | physical | 26344197 | |
PCBP1_HUMAN | PCBP1 | physical | 26344197 | |
PIPNA_HUMAN | PITPNA | physical | 26344197 | |
PPIL3_HUMAN | PPIL3 | physical | 26344197 | |
TALDO_HUMAN | TALDO1 | physical | 26344197 | |
ZBT43_HUMAN | ZBTB43 | physical | 27432908 | |
PPAC_HUMAN | ACP1 | physical | 27432908 | |
DJC13_HUMAN | DNAJC13 | physical | 27432908 | |
G45IP_HUMAN | GADD45GIP1 | physical | 27432908 | |
POTEE_HUMAN | POTEE | physical | 28514442 | |
ACTBL_HUMAN | ACTBL2 | physical | 28514442 | |
ACTB_HUMAN | ACTB | physical | 28514442 | |
INSR_HUMAN | INSR | physical | 9299573 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00173 | Adenine |
loading...
Acetylation | |
Reference | PubMed |
"Human red cell acid phosphatase (ACP1). The amino acid sequence ofthe two isozymes Bf and Bs encoded by the ACP1*B allele."; Dissing J., Johnsen A.H., Sensabaugh G.F.; J. Biol. Chem. 266:20619-20625(1991). Cited for: PROTEIN SEQUENCE (ALLELE B; ISOFORMS 1 AND 2). | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-156, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-132, AND MASSSPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-132, AND MASSSPECTROMETRY. | |
"Regulation of the low molecular weight phosphotyrosine phosphatase byphosphorylation at tyrosines 131 and 132."; Tailor P., Gilman J., Williams S., Couture C., Mustelin T.; J. Biol. Chem. 272:5371-5374(1997). Cited for: NUCLEOTIDE SEQUENCE (ISOFORM 2), TISSUE SPECIFICITY, PHOSPHORYLATIONAT TYR-132 AND TYR-133, AND MUTAGENESIS OF CYS-13; TYR-132 ANDTYR-133. |